{
    "medicine_id": "0c9876f5f5af3ae10e9a1d6ed95f5f6c38e08f1b",
    "platform_id": "12361",
    "metadata": {
        "name": "Sovaldi 400 mg film coated tablets",
        "composition": "Sovaldi 400 mg film coated tablets Each film coated tablet contains 400 mg of sofosbuvir For the full list of",
        "clinical_particulars": {
            "therapeutic_indications": "Sovaldi is indicated in combination with other medicinal products for the treatment of chronic hepatitis C CHC in adults and paediatric patients aged 3 years and above see sections 4 2 4 4 and 5 1 For hepatitis C virus HCV genotype specific activity see sections 4 4 and 5 1",
            "contraindications": {
                "disease": "Hypersensitivity to the active substance or to any of the excipients listed in section 6 1 Medicinal products that are strong P glycoprotein P gp inducers in the intestine carbamazepine phenobarbital phenytoin rifampicin and St John s wort Co administration will significantly decrease sofosbuvir plasma concentration and could result in loss of efficacy of Sovaldi see section 4 5",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Mannitol (E421);Microcrystalline cellulose;Croscarmellose sodium;Colloidal anhydrous silica;Magnesium stearate;Polyvinyl alcohol;Titanium dioxide;Macrogol;Talc;Iron oxide yellow",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2021-05-11"
    }
}